Tchaikapharma High Quality Medicines AD logo

7TH - Tchaikapharma High Quality Medicines AD Share Price

BGN12.5 0.0  0.0%

Last Trade - 10/07/20

Sector
Healthcare
Size
Mid Cap
Market Cap £483.6m
Enterprise Value £489.2m
Revenue £16.6m
Position in Universe 62nd / 633
Bullish
Bearish
Unlock 7TH Revenue
Momentum
Relative Strength (%)
1m +1.58%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High 0.000
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
29.0 30.0 33.1 33.4 38.1 34.7 +3.7%
+12.4 -13.4 +25.4 -11.4 +20.4 -75.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Tchaikapharma High Qulty Medcns AD Sofia revenues increased 17% to BGN10.9M. Net income decreased 37% to BGN2M. Revenues reflect Pills segment increase of 10% to BGN9.4M, Cans segment increase of 56% to BGN1.2M. Net income was offset by Purchase Value of Sold Assets increase from BGN35K to BGN145K (expense), Labor & Related Expenses in SGA increase of 10% to BGN920K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 7TH
Graphical History

Revenue

7TH Revenue Unlock 7TH Revenue

Net Income

7TH Net Income Unlock 7TH Revenue

Normalised EPS

7TH Normalised EPS Unlock 7TH Revenue

PE Ratio Range

7TH PE Ratio Range Unlock 7TH Revenue

Dividend Yield Range

7TH Dividend Yield Range Unlock 7TH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
7TH EPS Forecasts Unlock 7TH Revenue
Profile Summary

Tchaikapharma High Quality Medicines AD is a Bulgaria-based company engaged in the generic pharmaceuticals industry. The Company specializes in manufacture of both generic and in-licensed medicines destined for alimentary tract and metabolism and antiinfectitives for systemic use, as well as cardiovascular, musculoskeletal, nervous and other systems. It also offers solutions for injection and vitamins and nutritional supplements.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated March 14, 2000
Public Since May 21, 2015
No. of Shareholders: n/a
No. of Employees: 133
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Bulgarian Stock Exchange
Shares in Issue 84,500,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
7TH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 7TH
Upcoming Events for 7TH
Frequently Asked Questions for Tchaikapharma High Quality Medicines AD
What is the Tchaikapharma High Quality Medicines AD share price?

As of 10/07/20, shares in Tchaikapharma High Quality Medicines AD are trading at BGN12.5, giving the company a market capitalisation of £483.6m. This share price information is delayed by 15 minutes.

How has the Tchaikapharma High Quality Medicines AD share price performed this year?

Shares in Tchaikapharma High Quality Medicines AD are currently trading at BGN12.5 and the price has moved by 33.16% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Tchaikapharma High Quality Medicines AD price has moved by 43.03% over the past year.

What are the analyst and broker recommendations for Tchaikapharma High Quality Medicines AD?

There are no analysts currently covering Tchaikapharma High Quality Medicines AD.

When will Tchaikapharma High Quality Medicines AD next release its financial results?

Tchaikapharma High Quality Medicines AD is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Tchaikapharma High Quality Medicines AD dividend yield?

Tchaikapharma High Quality Medicines AD does not currently pay a dividend.

Does Tchaikapharma High Quality Medicines AD pay a dividend?

Tchaikapharma High Quality Medicines AD does not currently pay a dividend.

When does Tchaikapharma High Quality Medicines AD next pay dividends?

Tchaikapharma High Quality Medicines AD does not currently pay a dividend.

How do I buy Tchaikapharma High Quality Medicines AD shares?

To buy shares in Tchaikapharma High Quality Medicines AD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Tchaikapharma High Quality Medicines AD?

Shares in Tchaikapharma High Quality Medicines AD are currently trading at BGN12.5, giving the company a market capitalisation of £483.6m.

Where are Tchaikapharma High Quality Medicines AD shares listed? Where are Tchaikapharma High Quality Medicines AD shares listed?

Here are the trading details for Tchaikapharma High Quality Medicines AD:

Country of listing: Bulgaria
Exchange: BLG
Ticker Symbol: 7TH
What kind of share is Tchaikapharma High Quality Medicines AD?

Based on an overall assessment of its quality, value and momentum, Tchaikapharma High Quality Medicines AD is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Tchaikapharma High Quality Medicines AD share price forecast 2020?

We were not able to load any forecast data for Tchaikapharma High Quality Medicines AD.

How can I tell whether the Tchaikapharma High Quality Medicines AD share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tchaikapharma High Quality Medicines AD. Over the past six months, the relative strength of its shares against the market has been 34.81%. At the current price of BGN12.5, shares in Tchaikapharma High Quality Medicines AD are trading at 22.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Tchaikapharma High Quality Medicines AD PE Ratio?

The Tchaikapharma High Quality Medicines AD PE ratio based on its reported earnings over the past 12 months is 0.423k. The shares are currently trading at BGN12.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Tchaikapharma High Quality Medicines AD?

We were unable to find the directors for Tchaikapharma High Quality Medicines AD.

Who are the major shareholders of Tchaikapharma High Quality Medicines AD?

Here are the top five shareholders of Tchaikapharma High Quality Medicines AD based on the size of their shareholding:

Similar to 7TH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.